Long Term Performance Of Passive House Buildings

Long term experience with Passive House buildings is illustrated with two early large scale projects, a school and an office building located in Germany. Those were monitored in lump energy performance (school, commissioned 2004) and great detail (office, commissioned 2002) respectively. Moreover, they give an indication of the characteristics of such buildings subject to changes in usage intensity. Both buildings generally performed as expected with the school facing occasional overheating in the summer due to inflexible shading controls. Following an extension in schooling hours the addition of a canteen was required and the ventilation system was adapted to the changed usage. Nevertheless the building’s user comfort and energy performance remain high,despite exceeding the Passive House primary energy target slightly due to increased electricity consumption. The office likewise meets the calculated efficiency in operation. The ground coupled cooling worked well despite greatly increased internal heat gains due to unexpected usage. This extra heat input did not, however, exhaust the geothermal (passive) cooling capacity for the future. Thermal comfort proved near optimal at all times, despite a very simple control regime of the one-circuit concrete core activation system for heating and cooling. In the last section air tightness design and measurement experience in the UK and particularly the question of long-term stability of the airtight building envelope is assessed. It was found that measurement results are not only repeatable in relatively short intervals such as a few months. The data available suggests stability of the airtight envelope over many years. Attention is required as regards the leakage of party walls of terraced buildings which need to be integrated in the overall airtightness concept. A high permeability of party walls in terraced buildings with a common airtight envelope presents a challenge for measuring air tightness. Long-term series of airtightness measurements exist for the Kranichstein House in Darmstadt/Germany and prove the stability of the chosen airtightness concept. Moreover, results for 17 early Passive House buildings in Germany in eight locations and various construction types revisited in 2001 (1.4 to 10 years after the initial airtightness test) suggest stability of air tightness values over time. Great advances have since been made in materials and methods available and the general understanding in the industry. This is supported by a large sample of 2934 Passive House projects of varied construction materials, locations, sizes and usages that yielded an average air tightness test result as low as n50 = 0.41 h-1

Temperature in housing: stratification and contextual factors

Overheating in new and retrofit low carbon dioxide homes is a growing issue in the UK due to climate change and other factors, with 99% of existing housing predicted to be at medium to high risk if summer temperatures become 1·4°C warmer. A year-long field study in two residential developments in the north of England monitored housing at three different scales: two-storey houses and three- and ten-storey blocks of flats. This revealed significant temperature stratification in the staircase zone, which allows a stack effect, as well as temperature differences between dwellings depending on their location in the building, both for summer and winter conditions even in the low-rise housing. Further investigation revealed that albedo and east–west orientation also contributed to non-linear overheating. Analyses of inhabitants’ thermal comfort and security practices as well as occupancy patterns also challenge the regulatory modelling used to predict building performance. It is suggested that these additional physical as well as user factors in residential developments need further investigation and should now be considered in relation to thermal comfort modelling

The science of soundscape - summary of the evidence base from the UK acoustics community

The Science of Soundscape – Summary of the Evidence Base from the UK Acoustics Community provides a comprehensive summary of the scientific evidence supporting the use of a soundscape approach in environmental design and planning. The lead author was Peter Rogers; we contributed to the text with a case study, Soundscape approach for a residential development. The paper was written in response to a request from the UK House of Lords for information on the evidence base around soundscapes and their benefits for wellbeing. It provides background on the concept of soundscapes as distinct from just noise levels. Soundscapes consider the perception of sound in context. The paper summarizes evidence from many studies showing health and wellbeing benefits of natural sounds and positive soundscapes. Case studies demonstrate practical applications of soundscape principles in urban design projects. The paper calls for greater inclusion of soundscapes in policy frameworks, citing initial steps taken in Wales. It brings together views of many UK acoustics experts to give a broad scientific summary of the current state of knowledge on soundscapes. The paper makes the case for the science supporting soundscapes as a complement to traditional noise management, with benefits for human health and sustainability. It provides evidence requested by policymakers considering this approach

Subjective well-being and engagement in arts, culture and sport

This paper explores the relationship between engagement in arts, culture and sport, and subjective well-being, contributing to our understanding of the leisure experience, and cultural value, of these activities. Ordered probit analysis of UK data from wave 2 (2010-11) of Understanding Society , provides evidence in support of a wide range of cultural goods generating positive leisure experience, reflected in overall (life, general happiness) and domain (leisure) satisfaction. Frequency of engagement is central to certain activities: only regular participation in arts activities and sport generates positive effects. In contrast, arts events are positive irrespective of frequency. The findings also indicate even less frequent engagement in activities exhibiting cultural characteristics, e.g. museums/historical sites, has positive association with satisfaction. Finally, although employment has a negative association with leisure satisfaction, engagement in leisure activities is not found to spillover into job satisfaction (with the exception of certain sports). This suggests individuals consider work and leisure (including quality of leisure time) separately

The role of the fat mass and obesity associated gene (FTO) in breast cancer risk

<p>Abstract</p> <p>Background</p> <p>Obesity has been shown to increase breast cancer risk. <it>FTO </it>is a novel gene which has been identified through genome wide association studies (GWAS) to be related to obesity. Our objective was to evaluate tissue expression of FTO in breast and the role of FTO SNPs in predicting breast cancer risk.</p> <p>Methods</p> <p>We performed a case-control study of 354 breast cancer cases and 364 controls. This study was conducted at Northwestern University. We examined the role of single nucleotide polymorphisms (SNPs) of intron 1 of <it>FTO </it>in breast cancer risk. We genotyped cases and controls for four SNPs: rs7206790, rs8047395, rs9939609 and rs1477196. We also evaluated tissue expression of FTO in normal and malignant breast tissue.</p> <p>Results</p> <p>We found that all SNPs were significantly associated with breast cancer risk with rs1477196 showing the strongest association. We showed that FTO is expressed both in normal and malignant breast tissue. We found that <it>FTO </it>genotypes provided powerful classifiers to predict breast cancer risk and a model with epistatic interactions further improved the prediction accuracy with a receiver operating characteristic (ROC) curves of 0.68.</p> <p>Conclusion</p> <p>In conclusion we have shown a significant expression of FTO in malignant and normal breast tissue and that <it>FTO </it>SNPs in intron 1 are significantly associated with breast cancer risk. Furthermore, these <it>FTO </it>SNPs are powerful classifiers in predicting breast cancer risk.</p

A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial

Background Cough can be a debilitating symptom of idiopathic pulmonary fibrosis (IPF) and is difficult to treat. PA101 is a novel formulation of sodium cromoglicate delivered via a high-efficiency eFlow nebuliser that achieves significantly higher drug deposition in the lung compared with the existing formulations. We aimed to test the efficacy and safety of inhaled PA101 in patients with IPF and chronic cough and, to explore the antitussive mechanism of PA101, patients with chronic idiopathic cough (CIC) were also studied. Methods This pilot, proof-of-concept study consisted of a randomised, double-blind, placebo-controlled trial in patients with IPF and chronic cough and a parallel study of similar design in patients with CIC. Participants with IPF and chronic cough recruited from seven centres in the UK and the Netherlands were randomly assigned (1:1, using a computer-generated randomisation schedule) by site staff to receive PA101 (40 mg) or matching placebo three times a day via oral inhalation for 2 weeks, followed by a 2 week washout, and then crossed over to the other arm. Study participants, investigators, study staff, and the sponsor were masked to group assignment until all participants had completed the study. The primary efficacy endpoint was change from baseline in objective daytime cough frequency (from 24 h acoustic recording, Leicester Cough Monitor). The primary efficacy analysis included all participants who received at least one dose of study drug and had at least one post-baseline efficacy measurement. Safety analysis included all those who took at least one dose of study drug. In the second cohort, participants with CIC were randomly assigned in a study across four centres with similar design and endpoints. The study was registered with ClinicalTrials.gov (NCT02412020) and the EU Clinical Trials Register (EudraCT Number 2014-004025-40) and both cohorts are closed to new participants. Findings Between Feb 13, 2015, and Feb 2, 2016, 24 participants with IPF were randomly assigned to treatment groups. 28 participants with CIC were enrolled during the same period and 27 received study treatment. In patients with IPF, PA101 reduced daytime cough frequency by 31·1% at day 14 compared with placebo; daytime cough frequency decreased from a mean 55 (SD 55) coughs per h at baseline to 39 (29) coughs per h at day 14 following treatment with PA101, versus 51 (37) coughs per h at baseline to 52 (40) cough per h following placebo treatment (ratio of least-squares [LS] means 0·67, 95% CI 0·48–0·94, p=0·0241). By contrast, no treatment benefit for PA101 was observed in the CIC cohort; mean reduction of daytime cough frequency at day 14 for PA101 adjusted for placebo was 6·2% (ratio of LS means 1·27, 0·78–2·06, p=0·31). PA101 was well tolerated in both cohorts. The incidence of adverse events was similar between PA101 and placebo treatments, most adverse events were mild in severity, and no severe adverse events or serious adverse events were reported. Interpretation This study suggests that the mechanism of cough in IPF might be disease specific. Inhaled PA101 could be a treatment option for chronic cough in patients with IPF and warrants further investigation

Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls

Background The risk factors for recovery from COVID-19 dyspnoea are poorly understood. We investigated determinants of recovery from dyspnoea in adults with COVID-19 and compared these to determinants of recovery from non-COVID-19 dyspnoea. Methods We used data from two prospective cohort studies: PHOSP-COVID (patients hospitalised between March 2020 and April 2021 with COVID-19) and COVIDENCE UK (community cohort studied over the same time period). PHOSP-COVID data were collected during hospitalisation and at 5-month and 1-year follow-up visits. COVIDENCE UK data were obtained through baseline and monthly online questionnaires. Dyspnoea was measured in both cohorts with the Medical Research Council Dyspnoea Scale. We used multivariable logistic regression to identify determinants associated with a reduction in dyspnoea between 5-month and 1-year follow-up. Findings We included 990 PHOSP-COVID and 3309 COVIDENCE UK participants. We observed higher odds of improvement between 5-month and 1-year follow-up among PHOSP-COVID participants who were younger (odds ratio 1.02 per year, 95% CI 1.01–1.03), male (1.54, 1.16–2.04), neither obese nor severely obese (1.82, 1.06–3.13 and 4.19, 2.14–8.19, respectively), had no pre-existing anxiety or depression (1.56, 1.09–2.22) or cardiovascular disease (1.33, 1.00–1.79), and shorter hospital admission (1.01 per day, 1.00–1.02). Similar associations were found in those recovering from non-COVID-19 dyspnoea, excluding age (and length of hospital admission). Interpretation Factors associated with dyspnoea recovery at 1-year post-discharge among patients hospitalised with COVID-19 were similar to those among community controls without COVID-19. Funding PHOSP-COVID is supported by a grant from the MRC-UK Research and Innovation and the Department of Health and Social Care through the National Institute for Health Research (NIHR) rapid response panel to tackle COVID-19. The views expressed in the publication are those of the author(s) and not necessarily those of the National Health Service (NHS), the NIHR or the Department of Health and Social Care. COVIDENCE UK is supported by the UK Research and Innovation, the National Institute for Health Research, and Barts Charity. The views expressed are those of the authors and not necessarily those of the funders